BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 17699780)

  • 1. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
    Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
    Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
    Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
    Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to asphalt fumes activates activator protein-1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in mouse epidermal cells.
    Ma C; Wang J; Luo J
    J Biol Chem; 2003 Nov; 278(45):44265-72. PubMed ID: 12947100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
    Huang C; Ma WY; Young MR; Colburn N; Dong Z
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red Ginseng Oil Inhibits TPA-Induced Transformation of Skin Epidermal JB6 Cells.
    Truong VL; Kong AN; Jeong WS
    J Med Food; 2018 Apr; 21(4):380-389. PubMed ID: 29271701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
    Dong Z; Huang C; Ma WY
    Anticancer Res; 1999; 19(5A):3743-7. PubMed ID: 10625951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
    Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
    J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
    Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
    Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
    Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
    Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
    Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine.
    Nomura M; Ichimatsu D; Moritani S; Koyama I; Dong Z; Yokogawa K; Miyamoto K
    Mol Carcinog; 2005 Sep; 44(1):67-76. PubMed ID: 16044420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
    Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
    Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.
    Kim HG; Lee KW; Cho YY; Kang NJ; Oh SM; Bode AM; Dong Z
    Cancer Res; 2008 Apr; 68(7):2538-47. PubMed ID: 18381464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
    Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
    Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P
    Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH
    Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction.
    Nomura M; Yamazaki R; Takaya M; Kikuchi M; Takahashi-Nishioka T; Akiyama K; Akiyama N; Moritani S; Kobayashi S
    Anticancer Res; 2007; 27(5A):3187-93. PubMed ID: 17970060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.